STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #16 by analyst upside · 2026-08-14
FEMY
Femasys Inc.
Healthcare · Market Cap $7M · P/E 0x
ANALYST PRICE TARGET
+3393.4%
implied upside to consensus target
Current Price $2.29
Consensus Target $80.0
Bull Target $130.0
Bear Target $30.0
Analysts Covering 2
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $2.19
52-Week High $22.2
YTD Return -82.0%
FUNDAMENTALS
Market Cap $7M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-4.68
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $2.19
52-Week High $22.2
Current Price $2.29
Bear Target $30.0
Bull Target $130.0
● Now $2.29 ● Target $80.0
TRADING DATA
Avg Volume 111K
YTD Return -82.0%
Analyst Count 2
Consensus Strong Buy
Upside to Target +3393.4%
Last Updated 2026-08-14

ANALYST SUMMARY

Femasys Inc. (FEMY) is currently trading at $2.29 with a Wall Street consensus price target of $80.0, implying potential upside of 3393.4% over the next 12 months. 2 analysts currently cover FEMY, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $130.0, while the most cautious has a target of $30.0.

FEMY operates in the Healthcare sector with a market capitalisation of $7M. The stock is down 82.0% year-to-date and is currently trading near the lower end of its 52-week range of $2.19 – $22.2.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →